The trademark application PRORAMACE was filed by WIN MEDICA ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ με δ.τ. WIN MEDICA A.E., a corporation established under the laws of the Hellenic Republic (the "Applicant"). The application was published for oppositions on October 11, 2021, and it was registered by office on January 18, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Cardiovascular drugs for use in treating hypertension
Cardiovascular pharmaceuticals
Pharmaceutical preparations for treating hypertension
Pharmaceutical preparations for the treatment of cardiovascular disease
Pharmaceutical preparations for the treatment of heart rhythm disorders.